ARCHIVES

FDA Delays Decision On Avastin Approval For Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 34 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

FOCR Report Offers Recommendations, Definitions for CER

May 22, 2009

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

Randomized Trial Finds Sunscreen Use Cuts Risk Of Developing Melanoma

December 31, 2010

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994